Skip to main content
Top
Published in: European Journal of Nutrition 7/2019

01-10-2019 | Original Contribution

Non-immune-related hypothyroidism and its relationship with excess iodine

Authors: Hye In Kim, Hyun-Kyung Oh, So Young Park, Hye Won Jang, Myung-Hee Shin, Ji Min Han, Ji Cheol Bae, Sun Wook Kim, Tae Hyuk Kim, Jae Hoon Chung

Published in: European Journal of Nutrition | Issue 7/2019

Login to get access

Abstract

Purpose

In iodine-sufficient areas, autoimmune hypothyroidism has been regarded as the major subtype of hypothyroidism. Non-immune-related hypothyroidism has received little attention because it is considered to be rare. The aim of this study was to evaluate the prevalence of non-immune-related hypothyroidism in Korea and to identify its associating factors.

Methods

A total of 6434 participants in the Korea National Health and Nutrition Examination Survey VI (2013–2015) without known thyroid disease who were examined for thyroid stimulating hormone, free thyroxine, TPO Ab, and urine iodine concentration (UIC) were enrolled. The weighted proportions, demographic variables, and severity of immune-related and non-immune-related hypothyroidism were compared. To assess the effect of iodine on hypothyroidism in TPO Ab positive or negative populations, the weighted prevalence of hypothyroidism was assessed in each population according to UIC or estimated iodine intake subgroups.

Results

The prevalence of undetected hypothyroidism in Korea was 3.8% (n = 233). Of these 233 cases, 171 (71.8%) were non-immune-related. In the TPO Ab negative population, the prevalence of hypothyroidism was increased significantly in the subgroup with UIC between 250 and 749 µg/L (HR 2.12 [1.17, 3.83]) and ≥ 750 µg/L (HR 3.42 [1.93, 6.04]) or the subgroups with estimated iodine intake ≥ 750 µg/day (HR 2.81 [1.64, 4.80]).

Conclusions

This nationwide study demonstrated that most cases of hypothyroidism in iodine-sufficient areas are non-immune-related and are associated with excess iodine above a certain level. More attention to this unrecognized but widespread potential health risk is needed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chaker L, Bianco AC, Jonklaas J, Peeters RP (2017) Hypothyroidism. Lancet 390:1550–1562CrossRef Chaker L, Bianco AC, Jonklaas J, Peeters RP (2017) Hypothyroidism. Lancet 390:1550–1562CrossRef
2.
go back to reference Szabolcs I, Podoba J, Feldkamp J, Dohan O, Farkas I, Sajgo M, Takats KI, Goth M, Kovacs L, Kressinszky K, Hnilica P, Szilagyi G (1997) Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake. Clin Endocrinol (Oxf) 47:87–92CrossRef Szabolcs I, Podoba J, Feldkamp J, Dohan O, Farkas I, Sajgo M, Takats KI, Goth M, Kovacs L, Kressinszky K, Hnilica P, Szilagyi G (1997) Comparative screening for thyroid disorders in old age in areas of iodine deficiency, long-term iodine prophylaxis and abundant iodine intake. Clin Endocrinol (Oxf) 47:87–92CrossRef
3.
go back to reference Theodoropoulou A, Vagenakis AG, Makri M, Markou KB (2007) Thyroid hormone synthesis and secretion in humans after 80 milligrams of iodine for 15 days and subsequent withdrawal. J Clin Endocrinol Metab 92:212–214CrossRef Theodoropoulou A, Vagenakis AG, Makri M, Markou KB (2007) Thyroid hormone synthesis and secretion in humans after 80 milligrams of iodine for 15 days and subsequent withdrawal. J Clin Endocrinol Metab 92:212–214CrossRef
4.
go back to reference Vagenakis AG, Braverman LE (1975) Adverse effects of iodides on thyroid function. Med Clin N Am 59:1075–1088CrossRef Vagenakis AG, Braverman LE (1975) Adverse effects of iodides on thyroid function. Med Clin N Am 59:1075–1088CrossRef
5.
go back to reference Braverman LE, Ingbar SH (1963) Changes in thyroidal function during adaptation to large doses of iodide. J Clin Invest 42:1216–1231CrossRef Braverman LE, Ingbar SH (1963) Changes in thyroidal function during adaptation to large doses of iodide. J Clin Invest 42:1216–1231CrossRef
6.
go back to reference Wolff J, Chaikoff IL (1948) Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 174:555–564 Wolff J, Chaikoff IL (1948) Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 174:555–564
7.
go back to reference Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR (1998) Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 83:765–769CrossRef Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR (1998) Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 83:765–769CrossRef
8.
go back to reference Bulow Pedersen I, Knudsen N, Jorgensen T, Perrild H, Ovesen L, Laurberg P (2002) Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. J Clin Endocrinol Metab 87:4462–4469CrossRef Bulow Pedersen I, Knudsen N, Jorgensen T, Perrild H, Ovesen L, Laurberg P (2002) Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. J Clin Endocrinol Metab 87:4462–4469CrossRef
9.
go back to reference Li Y, Teng D, Shan Z, Teng X, Guan H, Yu X, Fan C, Chong W, Yang F, Dai H, Gu X, Yu Y, Mao J, Zhao D, Li J, Chen Y, Yang R, Li C, Teng W (2008) Antithyroperoxidase and antithyroglobulin antibodies in a 5-year follow-up survey of populations with different iodine intakes. J Clin Endocrinol Metab 93:1751–1757CrossRef Li Y, Teng D, Shan Z, Teng X, Guan H, Yu X, Fan C, Chong W, Yang F, Dai H, Gu X, Yu Y, Mao J, Zhao D, Li J, Chen Y, Yang R, Li C, Teng W (2008) Antithyroperoxidase and antithyroglobulin antibodies in a 5-year follow-up survey of populations with different iodine intakes. J Clin Endocrinol Metab 93:1751–1757CrossRef
10.
go back to reference Tran BT, Jeong BY, Oh JK (2017) The prevalence trend of metabolic syndrome and its components and risk factors in Korean adults: results from the Korean National Health and Nutrition Examination Survey 2008–2013. BMC Public Health 17:71CrossRef Tran BT, Jeong BY, Oh JK (2017) The prevalence trend of metabolic syndrome and its components and risk factors in Korean adults: results from the Korean National Health and Nutrition Examination Survey 2008–2013. BMC Public Health 17:71CrossRef
11.
go back to reference Kwon H, Kim WG, Jeon MJ, Han M, Kim M, Park S, Kim TY, Shong YK, Kim WB (2017) Age-specific reference interval of serum TSH levels is high in adolescence in an iodine excess area: Korea national health and nutrition examination survey data. Endocrine 57:445–454CrossRef Kwon H, Kim WG, Jeon MJ, Han M, Kim M, Park S, Kim TY, Shong YK, Kim WB (2017) Age-specific reference interval of serum TSH levels is high in adolescence in an iodine excess area: Korea national health and nutrition examination survey data. Endocrine 57:445–454CrossRef
12.
go back to reference Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, Wemeau JL (2013) 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J 2:215–228CrossRef Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, Wemeau JL (2013) 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J 2:215–228CrossRef
13.
go back to reference Amino N, Hagen SR, Yamada N, Refetoff S (1976) Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases. Clin Endocrinol (Oxf) 5:115–125CrossRef Amino N, Hagen SR, Yamada N, Refetoff S (1976) Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases. Clin Endocrinol (Oxf) 5:115–125CrossRef
15.
go back to reference Zimmermann MB, Andersson M (2012) Assessment of iodine nutrition in population: past, present, and future. Nutr Rev 70:553–570CrossRef Zimmermann MB, Andersson M (2012) Assessment of iodine nutrition in population: past, present, and future. Nutr Rev 70:553–570CrossRef
18.
go back to reference Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM (2014) Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid 24:1670–1751CrossRef Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM (2014) Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid 24:1670–1751CrossRef
19.
go back to reference Braverman LE, Cooper DS (2013) Introduction to hypothyroidism. In: Werner and Ingbar’s the thyroid, a fundamental and clinical text. Lippincott Williams & Wilkins, New York, pp 523–524 Braverman LE, Cooper DS (2013) Introduction to hypothyroidism. In: Werner and Ingbar’s the thyroid, a fundamental and clinical text. Lippincott Williams & Wilkins, New York, pp 523–524
20.
go back to reference Kim JY, Kim KR (2000) Dietary iodine intake and urinary iodine excretion in patients with thyroid diseases. Yonsei Med J 41:22–28CrossRef Kim JY, Kim KR (2000) Dietary iodine intake and urinary iodine excretion in patients with thyroid diseases. Yonsei Med J 41:22–28CrossRef
21.
go back to reference Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55–68CrossRef Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55–68CrossRef
22.
go back to reference Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K (1994) Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Clin Endocrinol Metab 78:393–397 Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K (1994) Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Clin Endocrinol Metab 78:393–397
23.
go back to reference Vitale M, Di Matola T, D’Ascoli F, Salzano S, Bogazzi F, Fenzi G, Martino E, Rossi G (2000) Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology 141:598–605CrossRef Vitale M, Di Matola T, D’Ascoli F, Salzano S, Bogazzi F, Fenzi G, Martino E, Rossi G (2000) Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology 141:598–605CrossRef
24.
go back to reference Teng X, Shan Z, Teng W, Fan C, Wang H, Guo R (2009) Experimental study on the effects of chronic iodine excess on thyroid function, structure, and autoimmunity in autoimmune-prone NOD.H-2h4 mice. Clin Exp Med 9:51–59CrossRef Teng X, Shan Z, Teng W, Fan C, Wang H, Guo R (2009) Experimental study on the effects of chronic iodine excess on thyroid function, structure, and autoimmunity in autoimmune-prone NOD.H-2h4 mice. Clin Exp Med 9:51–59CrossRef
25.
go back to reference Joung JY, Cho YY, Park SM, Kim TH, Kim NK, Sohn SY, Kim SW, Chung JH (2014) Effect of iodine restriction on thyroid function in subclinical hypothyroid patients in an iodine-replete area: a long period observation in a large-scale cohort. Thyroid 24:1361–1368CrossRef Joung JY, Cho YY, Park SM, Kim TH, Kim NK, Sohn SY, Kim SW, Chung JH (2014) Effect of iodine restriction on thyroid function in subclinical hypothyroid patients in an iodine-replete area: a long period observation in a large-scale cohort. Thyroid 24:1361–1368CrossRef
26.
go back to reference Kasagi K, Iwata M, Misaki T, Konishi J (2003) Effect of iodine restriction on thyroid function in patients with primary hypothyroidism. Thyroid 13:561–567CrossRef Kasagi K, Iwata M, Misaki T, Konishi J (2003) Effect of iodine restriction on thyroid function in patients with primary hypothyroidism. Thyroid 13:561–567CrossRef
27.
go back to reference Takamatsu J, Yoshida S, Yokozawa T, Hirai K, Kuma K, Ohsawa N, Hosoya T (1998) Correlation of antithyroglobulin and antithyroid-peroxidase antibody profiles with clinical and ultrasound characteristics of chronic thyroiditis. Thyroid 8:1101–1106CrossRef Takamatsu J, Yoshida S, Yokozawa T, Hirai K, Kuma K, Ohsawa N, Hosoya T (1998) Correlation of antithyroglobulin and antithyroid-peroxidase antibody profiles with clinical and ultrasound characteristics of chronic thyroiditis. Thyroid 8:1101–1106CrossRef
Metadata
Title
Non-immune-related hypothyroidism and its relationship with excess iodine
Authors
Hye In Kim
Hyun-Kyung Oh
So Young Park
Hye Won Jang
Myung-Hee Shin
Ji Min Han
Ji Cheol Bae
Sun Wook Kim
Tae Hyuk Kim
Jae Hoon Chung
Publication date
01-10-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 7/2019
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-018-1837-4

Other articles of this Issue 7/2019

European Journal of Nutrition 7/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.